rs751670999
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_019023.5(PRMT7):āc.1480T>Cā(p.Trp494Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,613,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_019023.5 missense
Scores
Clinical Significance
Conservation
Publications
- short stature-brachydactyly-obesity-global developmental delay syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRMT7 | NM_019023.5 | c.1480T>C | p.Trp494Arg | missense_variant | Exon 15 of 19 | ENST00000441236.3 | NP_061896.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250826 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461154Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 726922 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30513135, 30006058, 28902392, 33270637, 26437029) -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 266021). This missense change has been observed in individual(s) with short stature, brachydactyly, intellectual developmental disability, and seizures (SBIDDS) (PMID: 26437029, 28902392). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs751670999, gnomAD 0.003%). This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 494 of the PRMT7 protein (p.Trp494Arg). -
Short stature-brachydactyly-obesity-global developmental delay syndrome Pathogenic:1
- -
Inborn genetic diseases Uncertain:1
The c.1480T>C (p.W494R) alteration is located in exon 15 (coding exon 13) of the PRMT7 gene. This alteration results from a T to C substitution at nucleotide position 1480, causing the tryptophan (W) at amino acid position 494 to be replaced by an arginine (R). Based on data from gnomAD, the C allele has an overall frequency of 0.0008% (2/250826) total alleles studied. The highest observed frequency was 0.003% (1/34578) of Latino alleles. This alteration has been identified along with a second PRMT7 variant in three individuals with some features of PRMT7-related neurodevelopmental disorder; however, phase was unable to be determined in one case (Akawi, 2015; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at